
Mangoceuticals Investor Relations Material
Latest events

Q2 2025
14 Aug, 2025

Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mangoceuticals Inc
Access all reports
Mangoceuticals, Inc. is focused on the development, marketing, and sale of men's health and wellness products through a telemedicine platform. The company offers products under two main brands: Mango, which targets erectile dysfunction (ED), and Grow, which addresses hair loss. These products are marketed and sold directly to consumers online via the company’s website, leveraging a telehealth platform that connects users with licensed healthcare professionals for consultations and prescriptions. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
MGRX
Country
🇺🇸 United States